Cyclerion Therapeutics (CYCN) Other financing activities (2018 - 2022)
Cyclerion Therapeutics (CYCN) posted quarterly Other financing activities of $12000.0 for Q4 2022, down 85.88% year-over-year from $85000.0 in Q4 2021, and down 29.41% quarter-over-quarter from $17000.0 in Q2 2022.
Cyclerion Therapeutics (CYCN) Other financing activities (2018 - 2022) Analysis & Trends
Cyclerion Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $12000.0 for Q4 2022.
- In Q4 2022, Other financing activities fell 85.88% year-over-year to $12000.0; the TTM figure through Sep 2024 stood at $12000.0 (down 58.62% YoY), while the FY2023 annual figure was $24000.0, down 17.24% from the prior year.
- Other financing activities for Q4 2022 stood at $12000.0, down from $17000.0 in the prior quarter.
- The five-year high for Other financing activities was $128.6 million in Q3 2019, with the low at -$174.5 million in Q4 2019.
- The 5-year median for Other financing activities is $1.4 million (2019), against an average of $5.2 million.
- The sharpest annual moves came in 2019 and 2021: Other financing activities plunged 798.85% in 2019, then jumped 19685.71% in 2021.
- Cyclerion Therapeutics' Other financing activities stood at $25.0 million in 2018, then slumped by 798.85% to -$174.5 million in 2019, then soared by 86.29% to -$23.9 million in 2020, then surged by 100.36% to $85000.0 in 2021, then slumped by 85.88% to $12000.0 in 2022.
- Business Quant data shows CYCN's Other financing activities at $12000.0 in Q4 2022, $17000.0 in Q2 2022, and $85000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cyclerion Therapeutics | 12.71 Mn | 9.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Dec 31, 2021 | 85,000.00 |
| Dec 31, 2021 | 85,000.00 |
| Sep 30, 2021 | -30.30 Mn |
| Sep 30, 2021 | -30.30 Mn |
| Jun 30, 2021 | 30.47 Mn |
| Jun 30, 2021 | 30.47 Mn |
| Mar 31, 2021 | 27,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | -23.92 Mn |
| Dec 31, 2020 | -23.92 Mn |
| Sep 30, 2020 | 24.10 Mn |
| Sep 30, 2020 | 24.10 Mn |
| Jun 30, 2020 | 154,000.00 |
| Jun 30, 2020 | 154,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Mar 31, 2020 | 1,000.00 |